Switzerland Biotechnology & Medical Research

Molecular Partners AG (MOLN)

Track

Molecular Partners AG has recorded no insider trading activity within the past three months. The most recent transaction occurred on November 27, 2025, involving a sale of 35,000 shares. Historical data indicates sporadic divestment patterns by company insiders over several years, with the last purchase recorded in late 2023.
Ticker: MOLN Exchange: SWX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Executive Director / Officer
Transaction date
Sale
Price
138.70
Quantity 91,809
Value CHF2,759,901
Executive Director / Officer
Transaction date
Sale
Price
310.34
Quantity 89,322
Value CHF3,508,905
Executive Director / Officer
Transaction date
Purchase
Price
235.25
Quantity 98,205
Value CHF3,116,886
Executive Director / Officer
Transaction date
Purchase
Price
3.18
Quantity 10,000
Value CHF31,761
Executive Director / Officer
Transaction date
Sale
Price
26.78
Quantity 60,000
Value CHF1,607,000
Executive Director / Officer
Transaction date
Sale
Price
26.78
Quantity 60,000
Value CHF1,607,000
Executive Director / Officer
Transaction date
Sale
Price
26.78
Quantity 90,000
Value CHF2,410,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-27 2025-11-27 S Sale Executive Director / Officer
91,809
138.70
CHF2,759,901 		91,809 138.70 CHF2,759,901
2024-04-02 2024-04-02 S Sale Executive Director / Officer
89,322
310.34
CHF3,508,905 		89,322 310.34 CHF3,508,905
2023-11-01 2023-11-01 B Purchase Executive Director / Officer
98,205
235.25
CHF3,116,886 		98,205 235.25 CHF3,116,886
2023-11-01 2023-11-01 B Purchase Executive Director / Officer
10,000
3.18
CHF31,761 		10,000 3.18 CHF31,761
2022-02-15 2022-02-15 S Sale Executive Director / Officer
60,000
26.78
CHF1,607,000 		60,000 26.78 CHF1,607,000
2022-02-15 2022-02-15 S Sale Executive Director / Officer
60,000
26.78
CHF1,607,000 		60,000 26.78 CHF1,607,000
2022-02-15 2022-02-15 S Sale Executive Director / Officer
90,000
26.78
CHF2,410,500 		90,000 26.78 CHF2,410,500
Explore more

More insider trading research around Molecular Partners AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe
Insider trades in Swiss Performance Index